ProciseDx wins CE Mark for point-of-care tests September 10, 2020 -- Nestlé Health Science subsidiary ProciseDx has received the European CE Mark for Procise IFX and Procise ADL, the company's infliximab and adalimumab point-of-care diagnostics.
NIH to spend $129M to scale up COVID-19 testing September 2, 2020 -- The U.S. National Institutes of Health (NIH) plans to spend about $129 million to scale up COVID-19 testing capacity and provide manufacturing support. The agency has awarded contracts to nine companies for technologies such as portable point-of-care tests that can provide immediate results and high-throughput labs that can provide results within 24 hours.
FDA authorizes Abbott's COVID-19 real-time antigen test August 27, 2020 -- The U.S. Food and Drug Administration (FDA) has issued an emergency use authorization for a COVID-19 antigen test developed by Abbott Diagnostics Scarborough from which results can be read directly from the testing card.
Qiagen launches 10-minute SARS-CoV-2 test August 26, 2020 -- Qiagen announced the U.S. launch of a new digital SARS-CoV-2 detection test that can be done on a portable device. The device provides results in about 10 minutes, according to the company.
Point-of-care testing leads South Korea's response to COVID-19 August 24, 2020 -- What was the secret to South Korea's success in controlling the COVID-19 pandemic? A new study indicates that point-of-care testing played an important role in reducing the spread of SARS-CoV-2 there compared to the U.S., which has experienced 47 times the number of cases and almost 80 times the number of deaths. Discuss
Quidel closes Vermont investigation of Sofia test August 24, 2020 -- Quidel has completed its investigation of false-positive results for COVID-19 at a testing location in Vermont. The company said it found no testing site- or product-related issues with the Sofia 2 instrument or the Sofia immunoassay.